rs587778183
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_016507.4(CDK12):c.1913G>C(p.Gly638Ala) variant causes a missense change. The variant allele was found at a frequency of 0.00000434 in 1,612,144 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016507.4 missense
Scores
Clinical Significance
Conservation
Publications
- Tourette syndromeInheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152090Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.00000801 AC: 2AN: 249538 AF XY: 0.0000148 show subpopulations
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1460054Hom.: 0 Cov.: 34 AF XY: 0.00000275 AC XY: 2AN XY: 726212 show subpopulations
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152090Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74282 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1Other:1
The p.G638A variant (also known as c.1913G>C), located in coding exon 2 of the CDK12 gene, results from a G to C substitution at nucleotide position 1913. The glycine at codon 638 is replaced by alanine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at